Zacks Research Has Bearish Outlook for Chemours Q1 Earnings
The Chemours Company (NYSE:CC – Free Report) – Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Chemours in a research note issued to investors on Monday, March 3rd. Zacks Research analyst R. Department now forecasts that the specialty chemicals company will post earnings of $0.18 per share for the quarter, down […]
The Chemours Company (NYSE:CC – Free Report) – Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Chemours in a research note issued to investors on Monday, March 3rd. Zacks Research analyst R. Department now forecasts that the specialty chemicals company will post earnings of $0.18 per share for the quarter, down […]
